|
1
|
Onuora S: Osteoarthritis: Molecular
imaging detects activated macrophages. Nat Rev Rheumatol.
12:3132016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ma YW, Jiang DL, Zhang D, Wang XB and Yu
XT: Radial extracorporeal shock wave therapy in a person with
advanced osteonecrosis of the femoral head. Am J Phys Med Rehabil.
95:e133–e139. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee GW, Park KS, Kim DY, Lee YM,
Eshnazarov KE and Yoon TR: Results of total hip arthroplasty after
core decompression with tantalum rod for osteonecrosis of the
femoral head. Clin Orthop Surg. 8:38–44. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Roemer FW, Kwoh CK, Hannon MJ, Hunter DJ,
Eckstein F, Grago J, Boudreau RM, Englund M and Guermazi A: Partial
meniscectomy is associated with increased risk of incident
radiographic osteoarthritis and worsening cartilage damage in the
following year. Eur Radiol. 27:404–413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tang H, He S, Zhang X, Luo S, Zhang B,
Duan X, Zhang Z, Wang W, Wang Y and Sun Y: A network pharmacology
approach to uncover the pharmacological mechanism of XuanHuSuo
powder on osteoarthritis. Evid Based Complement Alternat Med.
2016:32469462016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Poquet N, Williams M and Bennell KL:
Exercise for Osteoarthritis of the Hip. Phys Ther. 96:1689–1694.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Maricar N, Callaghan MJ, Parkes MJ, Felson
DT and O'Neill TW: Clinical assessment of effusion in knee
osteoarthritis-A systematic review. Semin Arthritis Rheum.
45:556–563. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Beumer L, Wong J, Warden SJ, Kemp JL,
Foster P and Crossley KM: Effects of exercise and manual therapy on
pain associated with hip osteoarthritis: A systematic review and
meta-analysis. Br J Sports Med. 50:458–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Smyth NA, Haleem AM, Ross KA, Hannon CP,
Murawski CD, Do HT and Kennedy JG: Platelet-rich plasma may improve
osteochondral donor site healing in a rabbit model. Cartilage.
7:104–111. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fu CJ, Sun JB, Bi ZG, Wang XM and Yang CL:
Evaluation of platelet-rich plasma and fibrin matrix to assist in
healing and repair of rotator cuff injuries: A systematic review
and meta-analysis. Clin Rehabil. 31:158–172. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vannini F, Di Matteo B and Filardo G:
Platelet-rich plasma to treat ankle cartilage pathology - from
translational potential to clinical evidence: A systematic review.
J Exp Orthop. 2:22015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sadabad HN, Behzadifar M, Arasteh F,
Behzadifar M and Dehghan HR: Efficacy of platelet-rich plasma
versus hyaluronic acid for treatment of knee osteoarthritis: A
systematic review and meta-analysis. Electron Physician.
8:2115–2122. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Khoshbin A, Leroux T, Wasserstein D, Marks
P, Theodoropoulos J, Ogilvie-Harris D, Gandhi R, Takhar K, Lum G
and Chahal J: The efficacy of platelet-rich plasma in the treatment
of symptomatic knee osteoarthritis: A systematic review with
quantitative synthesis. Arthroscopy. 29:2037–2048. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hodge JA, Kawabata TT, Krishnaswami S,
Clark JD, Telliez JB, Dowty ME, Menon S, Lamba M and Zwillich S:
The mechanism of action of tofacitinib - an oral Janus kinase
inhibitor for the treatment of rheumatoid arthritis. Clin Exp
Rheumatol. 34:318–328. 2016.PubMed/NCBI
|
|
15
|
van der Goes MC, Jacobs JW and Bijlsma JW:
Rediscovering the therapeutic use of glucocorticoids in rheumatoid
arthritis. Curr Opin Rheumatol. 28:289–296. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Battaglia M, Guaraldi F, Vannini F, Rossi
G, Timoncini A, Buda R and Giannini S: Efficacy of
ultrasound-guided intra-articular injections of platelet-rich
plasma versus hyaluronic acid for hip osteoarthritis. Orthopedics.
36:e1501–e1508. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Laudy AB, Bakker EW, Rekers M and Moen MH:
Efficacy of platelet-rich plasma injections in osteoarthritis of
the knee: A systematic review and meta-analysis. Br J Sports Med.
49:657–672. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meheux CJ, McCulloch PC, Lintner DM,
Varner KE and Harris JD: Efficacy of intra-articular platelet-rich
plasma injections in knee osteoarthritis: A systematic review.
Arthroscopy. 32:495–505. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nahler G: Karnofsky performance status.
Dictionary of Pharmaceutical Medicine. 1–102. 2009. View Article : Google Scholar
|
|
20
|
Raeissadat SA, Rayegani SM, Hassanabadi H,
Fathi M, Ghorbani E, Babaee M and Azma K: Knee osteoarthritis
injection choices: Platelet-Rich Plasma (PRP) versus hyaluronic
acid (A one-year randomized clinical trial). Clin Med Insights
Arthritis Musculoskelet Disord. 8:1–8. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rodriguez-Merchan EC: Intraarticular
Injections of Platelet-rich Plasma (PRP) in the management of knee
osteoarthritis. Arch Bone Jt Surg. 1:5–8. 2013.PubMed/NCBI
|
|
22
|
Zalavras CG and Lieberman JR:
Osteonecrosis of the femoral head: Evaluation and treatment. J Am
Acad Orthop Surg. 22:455–464. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bai F, Tian H, Niu Z, Liu M, Ren G, Yu Y,
Sun T1, Li S and Li D: Chimeric anti-IL-17 full-length monoclonal
antibody is a novel potential candidate for the treatment of
rheumatoid arthritis. Int J Mol Med. 33:711–721. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gobbi A, Lad D and Karnatzikos G: The
effects of repeated intra-articular PRP injections on clinical
outcomes of early osteoarthritis of the knee. Knee Surg Sports
Traumatol Arthrosc. 23:2170–2177. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Filardo G, Kon E, DI Matteo B, DI Marino
A, Sessa A, Merli ML and Marcacci M: Leukocyte-poor PRP application
for the treatment of knee osteoarthritis. Joints. 1:112–120.
2014.PubMed/NCBI
|
|
26
|
Trotti A, Byhardt R, Stetz J, Gwede C,
Corn B, Fu K, Gunderson L, McCormick B, Morrisintegral M, Rich T,
et al: Common toxicity criteria: Version 2.0. an improved reference
for grading the acute effects of cancer treatment: Impact on
radiotherapy. Int J Radiat Oncol Biol Phys. 47:13–47. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Battaglia M, Guaraldi F, Vannini F, Buscio
T, Buda R, Galletti S and Giannini S: Platelet-rich plasma (PRP)
intra-articular ultrasound-guided injections as a possible
treatment for hip osteoarthritis: A pilot study. Clin Exp
Rheumatol. 29:7542011.PubMed/NCBI
|
|
28
|
Jang SJ, Kim JD and Cha SS: Platelet-rich
plasma (PRP) injections as an effective treatment for early
osteoarthritis. Eur J Orthop Surg Traumatol. 23:573–580. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pierce TP, Jauregui JJ, Elmallah RK,
Lavernia CJ, Mont MA and Nace J: A current review of core
decompression in the treatment of osteonecrosis of the femoral
head. Curr Rev Musculoskelet Med. 8:228–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kilincoglu V, Yeter A, Servet E, Kangal M
and Yildirim M: Short term results comparison of intraarticular
platelet-rich plasma (prp) and hyaluronic acid (ha) applications in
early stage of knee osteoarthritis. Int J Clin Exp Med.
8:18807–18812. 2015.PubMed/NCBI
|
|
31
|
Lebouvier A, Poignard A, Cavet M, Amiaud
J, Leotot J, Hernigou P, Rahmouni A, Bierling P, Layrolle P, Rouard
H and Chevallier N: Development of a simple procedure for the
treatment of femoral head osteonecrosis with intra-osseous
injection of bone marrow mesenchymal stromal cells: Study of their
biodistribution in the early time points after injection. Stem Cell
Res Ther. 6:682015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chiu WC, Lai YP and Chou MY: Humanization
and characterization of an anti-human TNF-α murine monoclonal
antibody. PLoS One. 6:e163732011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Weisman MH: TNF and anti-TNF treatment in
rheumatoid arthritis (RA). What we know and what we still need to
know. Ryumachi. 37:142–143. 1997.PubMed/NCBI
|
|
34
|
Elliot MJ, Maini RN, Feldmann M, Long-Fox
A, Charles P, Katasikis P, Brennan FM, Bijl H, Ghrayeb J and Woody
JN: Treatment of rheumatoid arthritis with chimeric monoclonal
antibodies to tumor necrosis factor alpha. Arthritis Rheum. 58 2
Suppl:S92–S101. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Segal B, Rhodus NL and Patel K: Tumor
necrosis factor (TNF) inhibitor therapy for rheumatoid arthritis.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 106:778–787.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Suzuki M, Tetsuka T, Yoshida S, Watanabe
N, Kobayashi M, Matsui N and Okamoto T: The role of p38
mitogen-activated protein kinase in IL-6 and IL-8 production from
the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial
fibroblasts. FEBS Lett. 465:23–27. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Görmeli G, Görmeli CA, Ataoglu B, Çolak C,
Aslantürk O and Ertem K: Multiple PRP injections are more effective
than single injections and hyaluronic acid in knees with early
osteoarthritis: A randomized, double-blind, placebo-controlled
trial. Knee Surg Sports Traumatol Arthrosc. 25:958–965. 2017.
View Article : Google Scholar : PubMed/NCBI
|
